MICHAEL S PERRY
CIK 1250379 · Chief Executive Officer · last filed 2025-12-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$12.49M
Companies
6
Total Filings
53
Lifetime Open-Market Net
-$11.94M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARWR | Director | 123,059 | $85.78 | $10.56M | -$8.32M | 24 | 2025-12-18 |
| RCEL | Chief Executive Officer | 406,525 | $4.61 | $1.87M | -$3.81M | 9 | 2022-11-22 |
| ARMP | Director | — | $4.73 | — | $0 | 1 | 2019-05-24 |
| Armata Pharmaceuticals, Inc. (APHB) Delisted | Director | 29,381 | — | — | $200.0K | 3 | 2018-03-26 |
| PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted | President & CMO | 81,860 | — | — | -$16.9K | 7 | 2011-04-14 |
| TGEN | Director | 20,000 | $3.10 | $62.0K | $0 | 3 | 2009-06-02 |
Recent Filings · Page 2 of 6
53 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-01-07 | ARWR | Grant (A) | +6,400 | $0 | EDGAR |
| 2022-01-04 | ARWR | Sell (S) | −4,500 | -$291.2K | EDGAR |
| 2021-12-27 | RCEL | Grant (A) | +71,440 | $0 | EDGAR |
| 2021-09-07 | RCEL | Mixed | +12,534 | -$232.0K | EDGAR |
| 2021-06-04 | RCEL | Sell (S) | −23,000 | -$398.6K | EDGAR |
| 2021-01-05 | ARWR | Mixed | +5,000 | -$304.4K | EDGAR |
| 2020-09-16 | RCEL | Mixed | +20,643 | -$1.30M | EDGAR |
| 2020-09-11 | RCEL | Mixed | +56,205 | -$707.6K | EDGAR |
| 2020-05-18 | ARWR | Exer (M) | +77,000 | $285.2K | EDGAR |
| 2020-05-13 | ARWR | Sell (S) | −36,000 | -$1.29M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.